Key result
Reverse Valsalva is linked to an ~11 bpm higher lowest heart rate versus standard Valsalva.
Why the study?
The Reverse Valsalva is a novel tool to restore sinus rhythm in paroxysmal supraventricular tachycardia, but its hemodynamic and autonomic effects compared to the Valsalva Maneuver were unknown.
Does the Reverse Valsalva maneuver differ from the Valsalva maneuver in cardiovascular hemodynamic and autonomic responses in healthy subjects?
Observational (n=15)
No
Does the Reverse Valsalva maneuver differ from the Valsalva maneuver in cardiovascular hemodynamic and autonomic responses in healthy subjects?
Absolute Event Rate: 70% vs 59%
p-value: p=<0.001
The Reverse Valsalva maneuver produces less heart rate slowdown and different autonomic activation patterns compared to the standard Valsalva maneuver in healthy subjects.
Reverse Valsalva produces less bradycardia than standard in healthy subjects; extends autonomic comparisons but leaves SVT termination efficacy open.
BACKGROUND: The Valsalva Maneuver (VM) is the first-line treatment for paroxysmal supraventricular tachycardia, but a recent, novel, and efficient tool to restore sinus rhythm has been described, i.e., the Reverse Valsalva (RV). This study aims to compare changes in cardiovascular hemodynamics and autonomic system activity (ANS) based on heart rate variability (HRV) analysis during both maneuvers. METHODS: Fifteen healthy participants performed the VM and RV maneuvers three times in a sitting position for durations of 15 s and 10 s, respectively. Blood pressure (BP) and heart rate (HR) were continuously monitored before, during and after the tests. Autonomic system activity was evaluated using frequency-domain analysis of HRV. RESULTS: The decrease in HR from baseline to the lowest values, expressed as a ratio, was similar during both maneuvers (0.81 during the RV vs. 0.79 during the VM, p = 0.27). However, the final lowest HR in response to the RV was higher than that in response to the VM, 70/min vs. 59/min (p <0.001). The activation of the autonomic nervous system during the most bradycardic phase of the RV (phase II) and VM (phase IV) showed that the total power of HRV was less prominent during the RV than during the VM (p <0.012), with similar levels of parasympathetic activation. CONCLUSIONS: Our results showed less HR slowdown during the RV than during the VM. The changes in HRV parameters during both procedures in particular phases of the RV and VM suggest that the autonomic nervous system is activated alternately, so these tests can be used complementarily in a clinical setting with different results.
No takes yet. Share an insight, caveat, or question.
Boryczko et al. (2023) conducted an observational in Healthy subjects (n=15). Reverse Valsalva Maneuver vs. Valsalva Maneuver was evaluated on Final lowest heart rate (beats/min) (p=<0.001). The Reverse Valsalva maneuver resulted in a higher final lowest heart rate compared to the standard Valsalva maneuver (70 vs. 59 beats/min, p <0.001), indicating less heart rate slowdown.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: